| Sub Cat | Epitope | |
|---|---|---|
| V3S-1124-YC2259 | The epitope is in a sequence WEPFA (TTR 41-45) and the E42G mutation prevents the clone binding. | |
| V3S-0522-YC2032 | The epitope is in a sequence GELHGLTTEEE (TTR 53-63) and the L55P mutation prevents antibody binding. | |
| V3S-0522-YC2031 | The epitope is in a sequence EEEFVEGIY (TTR 61-69) |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Transthyretin. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human, Mouse |
| Epitope | The epitope is in a sequence WEPFA (TTR 41-45) and the E42G mutation prevents the clone binding. |
| Isotype | IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; WB; IP |
| Application Notes | The antibody is recommended for detection of TTR by ELISA, WB, IP assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
